Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions
被引:48
作者:
Aberle, SW
论文数: 0引用数: 0
h-index: 0
机构:Univ Vienna, Inst Virol, A-1095 Vienna, Austria
Aberle, SW
Kletzmayr, J
论文数: 0引用数: 0
h-index: 0
机构:Univ Vienna, Inst Virol, A-1095 Vienna, Austria
Kletzmayr, J
Watschinger, B
论文数: 0引用数: 0
h-index: 0
机构:Univ Vienna, Inst Virol, A-1095 Vienna, Austria
Watschinger, B
Schmied, B
论文数: 0引用数: 0
h-index: 0
机构:Univ Vienna, Inst Virol, A-1095 Vienna, Austria
Schmied, B
Vetter, N
论文数: 0引用数: 0
h-index: 0
机构:Univ Vienna, Inst Virol, A-1095 Vienna, Austria
Vetter, N
Puchhammer-Stöckl, E
论文数: 0引用数: 0
h-index: 0
机构:Univ Vienna, Inst Virol, A-1095 Vienna, Austria
Puchhammer-Stöckl, E
机构:
[1] Univ Vienna, Inst Virol, A-1095 Vienna, Austria
[2] Univ Vienna, Dept Med, Div Nephrol & Dialysis, A-1095 Vienna, Austria
A line probe assay (INNO-LiPA HBV BR) detecting drug-resistant hepatitis B virus (HBV) strains was evaluated, Results concordant with sequence analysis were obtained with 48 of 56 serum samples from HBV-infected patients undergoing lamivudine therapy. In eight cases, additional minor subpopulations could be identified by the line probe assay.